Daniel Schneeberger

10% owner, InMed Pharmaceuticals Inc.; 10% owner, Tenax Therapeutics, Inc.; 10% owner, Rallybio Corp; 10% owner, Keros Therapeutics, Inc.

Bought, 12 months

$7.3M

Sold, 12 months

$0.0M

Companies

Latest trade

Sep 16, 2026

Companies

InMed Pharmaceuticals Inc.10% owner +$0.8M Tenax Therapeutics, Inc.10% owner +$3.2M Rallybio Corp10% owner +$3.3M Keros Therapeutics, Inc.10% owner −$95.7M

Trades

INM Bought 8,340 shares at $1.29 $0.0M Sep 16

INM Bought 54,256 shares at $1.30 $0.1M Sep 15

INM Bought 28,505 shares at $1.29 $0.0M Sep 14

TENX Bought 187,704 shares at $1.80 $0.3M Sep 2

TENX Bought 179,058 shares at $1.80 $0.3M Sep 1

TENX Bought 403,571 shares at $1.79 $0.7M Aug 31

TENX Bought 107,374 shares at $1.75 $0.2M Aug 24

TENX Bought 716,369 shares at $1.77 $1.3M Aug 21

TENX Bought 202,124 shares at $1.78 $0.4M Aug 20

INM Bought 468,551 shares at $1.54 $0.7M May 19

RLYB Bought 300 shares at $13.90 $0.0M May 15

RLYB Bought 79,259 shares at $13.99 $1.1M May 13

RLYB Bought 35,101 shares at $14.00 $0.5M May 5

RLYB Bought 120,804 shares at $13.97 $1.7M May 4

KROS Sold 5,389,264 shares at $17.75 $95.7M Oct 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.